Actor Matthew Perry's Death Investigation Nears Conclusion with Potential Charges Pending
Actor Matthew Perry's Death Investigation Nears Conclusion with Potential Charges Pending

Actor Matthew Perry's Death Investigation Nears Conclusion with Potential Charges Pending

News summary

The Los Angeles Police Department, alongside federal agencies including the DEA and the US Postal Inspection Service, is investigating the source of the ketamine that led to the death of actor Matthew Perry. Perry, known for his role in 'Friends,' was found dead at his Pacific Palisades home on October 28, 2023, with acute effects of ketamine and drowning cited as the cause of death. Despite undergoing ketamine infusion therapy for depression and anxiety, the ketamine in his system at the time of death was not from his prescribed treatment. Law enforcement sources suggest that 'multiple people' could face charges, pending a decision by the US Attorney's Office. The investigation is nearing its conclusion, focusing on who supplied the actor with the fatal dose. Perry's death has raised questions about the legality of the ketamine he used, as well as the broader implications for those involved in its distribution.

Story Coverage
Bias Distribution
80% Right
Information Sources
d387b58c-602b-49e7-8f0e-990aad2baa478f76b506-b4ea-4d97-9e25-107ba95ef15b78876203-7edc-4c1e-8422-d6a486707f9e605a98c4-d25e-430b-86c1-9232b14faa6b
+1
Left 20%
Right 80%
Coverage Details
Total News Sources
5
Left
1
Center
0
Right
4
Unrated
0
Last Updated
133 days ago
Bias Distribution
80% Right

Open Story Timeline

Story timeline 1Story timeline 2Story timeline 3Story timeline 4Story timeline 5Story timeline 6Story timeline 7Story timeline 8Story timeline 9Story timeline 10Story timeline 11Story timeline 12Story timeline 13Story timeline 14

Analyze and predict the
development of events

Related News
Ask VT AI
Story Coverage

Related Topics

Subscribe

Stay in the know

Get the latest news, exclusive insights, and curated content delivered straight to your inbox.

Related News
Recommended News